Herpes Zoster in Patients with Moderate to Severe Rheumatoid Arthritis Treated with Baricitinib

被引：0
|
作者：
Winthrop, Kevin L. [1 ]
Lindsey, Stephen [2 ]
Weinblatt, Michael [3 ]
Takeuchi, Tsutomu [4 ]
Hyslop, David [5 ]
Issa, Maher [5 ]
Chen, Lei [5 ]
Bradley, John [5 ]
Dickson, Christina [5 ]
Fleischmann, Roy [6 ,7 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Ochsner Med Ctr, Baton Rouge, LA USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA USA
[4] Keio Univ, Dept Internal Med, Div Rheumatol, Sch Med, Tokyo, Japan
[5] Eli Lilly & Co, Indianapolis, IN 46285 USA
[6] Metroplex Clin Res Ctr, Dallas, TX USA
[7] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3027
引用
收藏
页数：3
相关论文
共 50 条
  • [21] BUDGET IMPACT ANALYSIS OF TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN ADULT PATIENTS WITH BARICITINIB IN THE RUSSIAN FEDERATION
    Yagudina, R.
    Kulikov, A.
    Serpik, V
    Protsenko, M.
    VALUE IN HEALTH, 2019, 22 : S903 - S903
  • [22] Rates of herpes zoster in rheumatoid arthritis
    Smitten, A
    Simon, T
    Suissa, S
    Hochberg, MC
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 220 - 220
  • [23] Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Treated with Anti TNF-alpha Agents
    Dejaco, C.
    Duftner, C.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2009, 16 (03): : 142 - 143
  • [24] The Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis
    Zhuo, Ning
    Wang, Gang
    Wu, Gang
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (03) : 323 - 323
  • [25] Herpes Zoster and Tofacitinib Therapy in Patients with Rheumatoid Arthritis.
    Winthrop, K. L.
    Valdez, H.
    Mortensen, E.
    Chew, R.
    Krishnaswami, S.
    Kawabata, T.
    Riese, R.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1051 - S1051
  • [26] Rates and risk factors for Herpes Zoster in patients with rheumatoid arthritis
    Wolfe, F
    Michaud, K
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 103 - 104
  • [27] Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Ren, Shijie
    Bermejo, Inigo
    Simpson, Emma
    Wong, Ruth
    Scott, David L.
    Young, Adam
    Stevenson, Matt
    PHARMACOECONOMICS, 2018, 36 (07) : 769 - 778
  • [28] Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Shijie Ren
    Iñigo Bermejo
    Emma Simpson
    Ruth Wong
    David L. Scott
    Adam Young
    Matt Stevenson
    PharmacoEconomics, 2018, 36 : 769 - 778
  • [29] Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib
    Valor-Mendez, Larissa
    Manger, Bernhard
    Schett, Georg
    Kleyer, Arnd
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (10): : 980 - 983
  • [30] Tuberculosis, Potential Opportunistic Infections, and Other Infections of Interest in Patients with Moderate to Severe Rheumatoid Arthritis in the Baricitinib Program
    Winthrop, Kevin
    Lindsey, Stephen
    Harigai, Masayoshi
    Bradley, John D.
    Chen, Lei
    Hyslop, David L.
    Issa, Maher
    Nishikawa, Atsushi
    Witt, Sarah
    Dickson, Christina L.
    Dougados, Maxime
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345